Shoulder Innovations, Inc. (SI): Capital Expenditures
$7.41M
Year ended 2025-12-31
$9.99M
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.41M | +84.5% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $4.01M | n/a | 2026-03-10, From 2024-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $7.41M | +84.5% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $918.0K | +166.1% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $642.0K | +256.7% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $1.94M | +296.3% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $3.66M | +453.2% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $1.11M | +54.3% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $932.5K | -28.1% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $580.0K | -57.4% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $356.0K | -59.4% |
Compare SI, TLSI, CARL, SNWV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗